share_log

JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $110

Benzinga ·  Dec 17 00:51  · Ratings

JP Morgan analyst Robbie Marcus maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target from $100 to $110.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment